Trending at Lumira Ventures

OpSens Announces 1,000th SavvyWire Procedure

Alyssia Watkin Portfolio News, Opsens

OpSens Inc. (“OpSens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, announced a significant milestone for the Company as the SavvyWire has been successfully used by physicians in 1,000 procedures. The SavvyWire is …

Opsens Receives FDA Approval for Optowire III

Jennifer Schram Portfolio News, Opsens

QUEBEC CITY /CNW Telbec/ – Opsens Inc. (“Opsens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF) today announced 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its OptoWire III, a coronary pressure guidewire for physiological measurements such as Fractional Flow Reserve …

Opsens Reports FY2019 Revenues of $32.8M, up 36%

Jennifer Schram Portfolio News, Opsens

QUEBEC CITY, Quebec – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for 2019. Highlights For the Quarter and The Year Record consolidated revenues at $32.8 M for FY2019 compared with $24.1 M for FY2018, a 36% increase; Fractional Flow …

Opsens Releases Promising Q3 2019 Financials

Jennifer Schram Portfolio News, Opsens

QUEBEC CITY, July 11, 2019 /CNW Telbec/ – Opsens Inc. (“Opsens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF) today reported its results for the third quarter of 2019. HIGHLIGHTS Consolidated revenues of $7.9 M for the third quarter of 2019 compared with $6.4 M for the third quarter of 2018, an increase …

Opsens Q2 2019 Revenues Reach a Record Level

Jennifer Schram Portfolio News, Opsens

QUEBEC CITY, April 11, 2019 /CNW Telbec/ – Opsens Inc. (“Opsens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF) today reported its results for the second quarter of 2019. HIGHLIGHTS Consolidated revenues totaled $7.9M in the second quarter of 2019 compared with $5.4M in the corresponding period in 2018, an increase of $2.5M or …

Opsens Applauds Japanese Government New Regulation Supporting Diagnosis, Such as FFR, Before Treatment of Coronary Stenosis

jacki jenuth Portfolio News, Opsens

Quebec City, Quebec, April 24, 2018 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS)(OTCQX:OPSSF) applauds Japan’s Ministry of Health, Labor and Welfare (“MHLW”) on its new regulation requiring the evaluation of any coronary stenosis prior to its treatment, specifically mentioning Fractional Flow Reserve (“FFR”) as …

Opsens Inc. Opens the Market

admin Portfolio News, Opsens

Monday, March 13, 2017 Louis Laflamme, President & Chief Executive Officer, Opsens Inc. (OPS), joined Ungad Chadda, President, Capital Formation, Equity Capital Markets, TMX Group to open the market. Opsens focuses mainly on the measure of Fractional Flow Reserve (FFR) …

Opsens Announces Graduation to TSX

admin Portfolio News, Opsens

QUEBEC CITY, Feb. 28, 2017 /CNW Telbec/ – Opsens Inc. (“Opsens” or the “Company”) (TSXV: OPS) (OTCQX: OPSSF) is pleased to announce that it has received final approval for the listing of the Corporation’s common shares (the “Common Shares”) on …